Participants with small cell lung cancer with brain metastases for Small Cell Lung Carcinoma
Phase-Based Progress Estimates
Effectiveness
Safety
Memorial Sloan Kettering Nassau, Rockville Centre, NY
Small Cell Lung Carcinoma+9 More
Cerebrospinal fluid collection - ProcedureEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.
Eligible Conditions
- Small Cell Lung Carcinoma
- Tumors Metastatic to Brain
- Brain Metastases, Adult
- Small-cell Lung Cancer
- Metastatic Lung Cancer
- Lung Cancers
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 6 months
6 months
Overall survival
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Trial Design
1 Treatment Group
Participants with small cell lung cancer with brain metastases
1 of 1
Experimental Treatment
62 Total Participants · 1 Treatment Group
Primary Treatment: Participants with small cell lung cancer with brain metastases · No Placebo Group · Phase 2
Participants with small cell lung cancer with brain metastasesExperimental Group · 2 Interventions: Cerebrospinal fluid collection, Stereotactic Radiosurgery · Intervention Types: Procedure, Radiation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cerebrospinal fluid collection
2015
N/A
~220
Stereotactic Radiosurgery
2012
Completed Phase 2
~320
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
Closest Location: Memorial Sloan Kettering Nassau · Rockville Centre, NY
2020First Recorded Clinical Trial
9 TrialsResearching Small Cell Lung Carcinoma
36 CompletedClinical Trials
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have a histologic diagnosis of small cell lung cancer.
You have at least 10 brain metastases on contrast-enhanced MRI.
You have a performance status of 60-100/ECOG 0-2.
You are female and of reproductive potential or have a negative serum pregnancy test at the time of enrollment.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments